News & Updates

Latest News & Updates

You are invited to attend a complimentary session on Applying Practical Strategies for the Treatment and Management of Patients with CLL.

OFD and DI 2022 take place on Saturday, October 22 and Sunday October 23, 2022 as a two day CCCEP accredited online learning event. Register now!

Have you ever done research and thought about publishing it but didn’t know how to get started?

An Expert Steering Committee of Oncology Pharmacists has developed an exciting, new, virtual program for pharmacists looking to broaden their knowledge on the fundamentals of oncology, called the ABC program (Addressing the Basics in Cancer).

Join us for a conversation about self leadership in pharmacy with Maria Anwar.

CAPhO Connections Podcast Series keeps the oncology pharmacy community informed on matters affecting you and updated on CAPhO’s news related to education, awards, advocacy and research.

Viatris Inc. announced that Abevmy® is now available in Canada. Abevmy, is a biosimilar to Roche’s Avastin® (bevacizumab) and has been authorized for use by Health Canada across four oncology indications.

Many pharmacist-led and CAPhO-supported research initiatives are contributing significantly to advancing cancer care in Canada.

A needs assessment on the management of chronic lymphocytic leukemia (CLL) developed by a multidisciplinary committee of fellow healthcare providers is available!

We are very pleased to announce that applications for the 2nd annual HOPE (Honouring Oncology Pharmacy Excellence) Awards in Pharmacy are now open! The HOPE Awards honour and recognize accomplishments of oncology pharmacists across Canada.

Can you identify hazardous drug contamination in less than 10 minutes? BD® HD Check is an easy-to-use system to protect your facility from the risk of hazardous drug exposure.

Apotex is proud to be delivering important savings to the Canadian Healthcare System, and to patients with Multiple Myeloma and Myelodysplastic Syndrome, with our MADE IN CANADA lenalidomide product.